Michael Pitts

Michael Pitts is an experienced professional in the pharmaceutical and sales industries, currently serving as an Area Development Manager at Rhythm Pharmaceuticals Inc. since August 2021, focusing on awareness-building for melanocortin 4 receptor pathway diseases and engaging with key opinion leaders. Previous roles include a Regional Sales Representative at Evofem Biosciences, where Phexxi was launched, and a Key Account Manager at Sage Therapeutics, responsible for the launch of Zulresso. Further experience includes specialty sales at AMAG Pharmaceuticals with Makena, medical device sales at VQ OrthoCare, and professional sales with Shire, where notable medications were introduced to healthcare professionals. Michael Pitts holds a Bachelor of Science degree in Business Administration from California Polytechnic State University-San Luis Obispo.